Future trends in human brucellosis treatment
Authors:
- 21 September 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Investigational Drugs
- Vol. 15 (10) , 1141-1149
Abstract
(2006). Future trends in human brucellosis treatment. Expert Opinion on Investigational Drugs: Vol. 15, No. 10, pp. 1141-1149. doi: 10.1517/13543784.15.10.1141Keywords
This publication has 59 references indexed in Scilit:
- Proteomic analysis of Brucella abortus cell envelope and identification of immunogenic candidate proteins for vaccine developmentProteomics, 2006
- Evaluation of Brucella abortus DNA vaccine by expression of Cu–Zn superoxide dismutase antigen fused to IL-2Immunobiology, 2006
- Quinolones for Treatment of Human Brucellosis: Critical Review of the Evidence from Microbiological and Clinical StudiesAntimicrobial Agents and Chemotherapy, 2006
- BrucellosisNew England Journal of Medicine, 2005
- Induction of Partial Protection in Mice after Oral Administration ofLactococcus lactisProducingBrucella abortusL7/L12 AntigenJournal of Drug Targeting, 2003
- Nucleic acid vaccination of Brucella abortus ribosomal L7/L12 gene elicits immune responseVaccine, 1997
- Recognition and Optimum Treatment of BrucellosisDrugs, 1997
- Immunization of mice with recombinant L7L12 ribosomal protein confers protection against Brucella abortus infectionVaccine, 1996
- Immunotherapy in Chronic Brucellosis. Effect of Levamisole and Interferon; Mechanisms of Action and Clinical ValueImmunopharmacology and Immunotoxicology, 1994
- CLINICAL CATEGORIES OF NEUROBRUCELLOSISBrain, 1987